학술논문
Re-assessing Evidence for Adverse Ocular Reactions Associated with Fluoroquinolones: Implications for Intracameral Use.
Document Type
Editorial
Author
Source
Subject
Language
ISSN
0927-3948
Abstract
Although corneal endothelial toxicity studies are reassuring that intracameral moxifloxacin is safe, several studies suggest moxifloxacin may be toxic to iris melanocytes and retinal vascular cells.[11]-[13] Topical preparations of moxifloxacin penetrate the cornea and achieve higher aqueous concentrations than older, commercially available fluoroquinolones. Bilateral uveitis associated with fluoroquinolone therapy. Moxifloxacin concentration and proteomic analysis of aqueous humor in human uveitis associated with oral moxifloxacin therapy. [Extracted from the article]